Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients

Nicola Polverelli, Paolo Tura, Giorgia Battipaglia, MD, Gandolfi Lisa, Tatiana Zollner, MD, Michele Malagola, MD, Enrico Morello, MD, Alessandro Turra, MD, Simona Bernardi, PhD, Camilla Zanaglio, PhD, Federica Re, Mohamad Mohty, MD PhD, Domenico Russo, MD

Blood (2019) 134 (Supplement_1): 41.

https://doi.org/10.1182/blood-2019-127026

Published: 2019

Journal Articles

ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience

Blood (2018) 132 (Supplement 1): 3381.

https://doi.org/10.1182/blood-2018-99-110252

Published: 2018

Journal Articles

Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach

Simona Bernardi, PhD, Camilla Zanaglio, PhD, Elif Dereli Eke, PhDStudent, Federica Cattina, MD PhD, Mirko Farina, MD, Stefania Masneri, PhD, Benedetta Rambaldi, MD, Francesca Schieppati, MD, Alessandro Turra, MD, Nicola Polverelli, MD, Enrico Morello, MD, Michele Malagola, MD, Domenico Russo, MD

Blood (2018) 132 (Supplement 1): 4387.

https://doi.org/10.1182/blood-2018-99-109927

Published: 2018

Journal Articles

A Prospective, Non-Randomized, Multicenter, Phase II Study to Assess Safety and Efficacy of the Infusion of Peripheral Blood Stem Cells Obtained from HLA-Haploidentical Familial Donors (mHaploSCI) after Standard Chemotherapy in Elderly Patients with Acute Myeloid Leukemia at Intermediate or Adverse Risk

Mirko Farina, MD, Massimo Bernardi, MD, Valentina Mancini, MD, Arnalda Lanfranchi, Alessandra Beghin, Enrico Morello, MD, Marta Petullà, Erika Borlenghi, Chiara Cattaneo, MD, Roberto Cairoli, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 4464.

https://doi.org/10.1182/blood.V130.Suppl_1.4464.4464

Published: 2017

Journal Articles

Bortezomib-Based Induction Regimen Followed By Autologous Stem Cell Transplantation (ASCT) after Conditioning with MEL200 Is Highly Effective and Well Tolerated in Elderly Multiple Myeloma (MM) Patients up to the Age of 75 Years

Angelo Belotti, MD, Rossella Ribolla, MD, Claudia Crippa, MD, Chiara Cattaneo, MD, Enrico Morello, MD, Vincenza Orlando, PharmD, Nicola Bianchetti, MD, Samantha Ferrari, MD, Chiara Bottelli, MD, Francesca Schieppati, MD, Aldo M. Roccaro, Marco Chiarini, Mario Morone, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 3161.

https://doi.org/10.1182/blood.V130.Suppl_1.3161.3161

Published: 2017

Journal Articles

Autologous Stem Cell Transplant (ASCT) Improves the Prognosis of AL Amyloidosis By Inducing a Higher Organ Response Rates and May be Preferred As First Line Treatment Both in AL and in AL Associated with Multiple Myeloma (MM)

Angelo Belotti, MD, Rossella Ribolla, MD, Claudia Crippa, Vincenza Orlando, PharmD, Mariella D'Adda, MD, Alessandro Re, MD, Enrico Morello, MD, Chiara Cattaneo, MD, Giuseppe Rossi

Blood (2016) 128 (22): 4634.

https://doi.org/10.1182/blood.V128.22.4634.4634

Published: 2016

Journal Articles

The Detection of Minimal Residual Disease By Multiparameter Flow Cytometry Predicts a Higher Risk of Relapse in Patients with ELN Intermediate Risk Acute Myeloid Leukemia Where Molecular Markers Are Not Available

Erika Borlenghi, MD, Mirko Farina, MD, Marco Chiarini, MSC, Viviana Giustini, MSC, Cinzia Lamorgese, Angela Passi, MD, Enrico Morello, MD, Luisa Imberti, MD, Giuseppe Rossi, MD

Blood (2016) 128 (22): 2882.

https://doi.org/10.1182/blood.V128.22.2882.2882

Published: 2016

Journal Articles

90Yttrium-Ibritumomab Tiuxetan for Non-Hodgkin Lymphoma: Results after a Median Follow-up of 5 Years in a Single Institution

Antonella Anastasia, Enrico Morello, MD, Alessandra Tucci, MD, Alessandro Re, MD, Marina Motta, MD, Chiara Pagani, MD, Raffaele Giubbini, Giancarlo Magri, Marta Petullà, Giuseppe Rossi, MD

Blood (2014) 124 (21): 4455.

https://doi.org/10.1182/blood.V124.21.4455.4455

Published: 2014

Journal Articles

High Dose Melphalan Followed By Autologous Stem Cell Transplant in AL Amyloidosis: a Single-Center Experience

Mariella D'Adda, MD, Francesca Schieppati, MD, Samantha Ferrari, MD, Claudia Crippa, MD, Annalisa Peli, MD, Alessandro Re, MD, Enrico Morello, MD, Paola Tozzi, PharmD, Vincenza Orlando, PharmD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 5909.

https://doi.org/10.1182/blood.V124.21.5909.5909

Published: 2014

Journal Articles

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Michele Malagola, Crisitina Skert, Enrico Morello, MD, Francesca Antoniazzi, MD, Erika Borlenghi, MD, Alessandro Turra, Chiara Pagani, MD, Rossella Ribolla, Valeria Cancelli, Federica Cattina, MD PhD, Elisa Alghisi, Simona Bernardi, Simone Perucca, Andrea Di Palma, Giuseppina Ruggeri, Giuseppe Rossi, Luigi Caimi, Domenico Russo, MD

Blood (2014) 124 (21): 3695.

https://doi.org/10.1182/blood.V124.21.3695.3695

Published: 2014

Journal Articles

Role of Histopathology in Management of Graft Versus Host Disease (GVHD). A Single Centre Experience.

Irene Maria Cavattoni, MD, Enrico Morello, MD, Norbert Pescosta, MD, Marco Casini, MD, Giovanni Negri, Vito Colombetti, Sergio Cortelazzo, MD

Blood (2009) 114 (22): 4647.

https://doi.org/10.1182/blood.V114.22.4647.4647

Published: 2009

Journal Articles

Peripheral Stem Cell Mobilization with Chemotherapy + G-CSF Priming in a Large Series of Patients with Lymphoma Candidates to Autologous Transplantation. An Analysis of Baseline and Ongoing Predictors of Failure or Suboptimal Stem Cell Collection.

Enrico Morello, MD, Camillo Almici, MD, Luca Arcaini, MD, Liliana Baushi, MD, Barbara Botto, MD, Andrea Castelli, MD, Annamaria Nosari, MD, Gianmatteo Pica, MD, Francesco Ripamonti, MD, Flavia Salvi, MD, Angelo Michele Carella, Prof, Gianluca Gaidano, MD, PhD, Alessandro Levis, MD, Enrica Morra, MD, Umberto Vitolo, MD, Rossi Giuseppe, MD

Blood (2009) 114 (22): 2149.

https://doi.org/10.1182/blood.V114.22.2149.2149

Published: 2009

Journal Articles

RIC Allogeneic Transplantation Improves the Overall and Progression- Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLATyping and Donor Availability

Barbara Sarina, MD, Luca Castagna, MD, Fabio Benedetti, MD, Francesca Patriarca, MD, Michele Malagola, MD, Silvia Ferrari, MD, Roberto Sorasio, MD, Lucia Farina, MD, Enrico Morello, MD, Alessandro Bonini, MD, Nicola Mordini, MD, Sergio Tamiazzo, MD, Michele Falda, MD, Laura Giordano, PhD, Paolo Corradini, MD

Blood (2008) 112 (11): 460.

https://doi.org/10.1182/blood.V112.11.460.460

Published: 2008

Journal Articles

IFN-γ Induced by PHA Stimulation as New Marker for Gvhd Prediction in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Enrico Morello, MD, Vladia Monsurrò, Ph.D., Elisabetta Pagani, Ph.D., Irene Cavattoni, MD, Silvia Coin, Giuseppe Tridente, Clara Larcher, MD, Sergio Cortelazzo, MD

Blood (2008) 112 (11): 2196.

https://doi.org/10.1182/blood.V112.11.2196.2196

Published: 2008

Journal Articles

Impact of Prophylaxis with Aerosolized Amphotericin-B Deoxycholate (d-AmB) on Respiratory Tract Invasive Fungal Infections (IFIs) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Enrico Morello, MD, Irene M. Cavattoni, M.D., Pietro Fabris, M.D., Silvia Coin, B.S.C., Barbara Amato, M.D., Vincenzo Cassibba, M.D., Marco Casini, M.D., Leonardo Pagani, M.D., Sergio Cortelazzo, M.D.

Blood (2007) 110 (11): 4986.

https://doi.org/10.1182/blood.V110.11.4986.4986

Published: 2007

Journal Articles

Outcome of Adult AML at First Relapse Following a Risk-Oriented Strategy: The Northern Italy Leukemia Group (NILG) Experience.

Irene M. Cavattoni, MD, Enrico Morello, MD, Michael Mian, MD, Elena Oldani, Biol.Sc., Tamara Intermesoli, MD, Erika Borlenghi, MD, Giuseppe Rossi, MD, Claudia Minotto, MD, Elisabetta Terruzzi, MD, Enrico Maria Pogliani, Ernesta Audisio, MD, Filippo Marmont, MD, Alessandro Rambaldi, MD, Renato Bassan, MD, Sergio Cortelazzo, MD

Blood (2006) 108 (11): 5380.

https://doi.org/10.1182/blood.V108.11.5380.5380

Published: 2006

Journal Articles

Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients Older Than 60 Years.

Alessandro Busca, MD, Franco Locatelli, MD, Stella Santarone, MD, Franco Narni, MD, Enrico Morello, MD, Alessandro Rambaldi, MD, Nicola Mordini, MD, Benedetto Bruno, MD, Andrea Bacigalupo, MD, Michele Falda, MD

Blood (2004) 104 (11): 5134.

https://doi.org/10.1182/blood.V104.11.5134.5134

Published: 2004

NARROW

Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients

ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience

Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach

Bortezomib-Based Induction Regimen Followed By Autologous Stem Cell Transplantation (ASCT) after Conditioning with MEL200 Is Highly Effective and Well Tolerated in Elderly Multiple Myeloma (MM) Patients up to the Age of 75 Years

Autologous Stem Cell Transplant (ASCT) Improves the Prognosis of AL Amyloidosis By Inducing a Higher Organ Response Rates and May be Preferred As First Line Treatment Both in AL and in AL Associated with Multiple Myeloma (MM)

The Detection of Minimal Residual Disease By Multiparameter Flow Cytometry Predicts a Higher Risk of Relapse in Patients with ELN Intermediate Risk Acute Myeloid Leukemia Where Molecular Markers Are Not Available

90Yttrium-Ibritumomab Tiuxetan for Non-Hodgkin Lymphoma: Results after a Median Follow-up of 5 Years in a Single Institution

High Dose Melphalan Followed By Autologous Stem Cell Transplant in AL Amyloidosis: a Single-Center Experience

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Role of Histopathology in Management of Graft Versus Host Disease (GVHD). A Single Centre Experience.

Peripheral Stem Cell Mobilization with Chemotherapy + G-CSF Priming in a Large Series of Patients with Lymphoma Candidates to Autologous Transplantation. An Analysis of Baseline and Ongoing Predictors of Failure or Suboptimal Stem Cell Collection.

RIC Allogeneic Transplantation Improves the Overall and Progression- Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLATyping and Donor Availability

IFN-γ Induced by PHA Stimulation as New Marker for Gvhd Prediction in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Impact of Prophylaxis with Aerosolized Amphotericin-B Deoxycholate (d-AmB) on Respiratory Tract Invasive Fungal Infections (IFIs) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Outcome of Adult AML at First Relapse Following a Risk-Oriented Strategy: The Northern Italy Leukemia Group (NILG) Experience.

Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients Older Than 60 Years.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only